Double Eagle Holdings, Ltd. (Pink Sheets: DEGH) announced today that Jeanne Hebert – a former sales and marketing executive at Integral Orthopedics, Bayer, and Merck – has joined the company's advisory Board of Directors. Double Eagle Holdings is the parent company of Fuse Science, Inc. (www.fusescience.com), developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. Hebert brings more than 20 years sales, marketing and research experience in the pharmaceutical and medical device industries, having worked for leading global manufacturers Bristol-Myers Squibb, Bayer Pharmaceutical, Merck & Co. and Integral Orthopedics Inc.
During her tenure at Merck, she provided direction on science-based content to support Merck's strategic objectives in the Respiratory and Ophthalmology franchises. As a member of the Scientific Advisory Board, she created the scientific platform for the Respiratory Health Science organization. In addition to crafting compelling sales messages from the supporting science, her role involved identifying and engaging thought leaders (leading researchers and academics), in peer-level, scientific discussions to convert them into advocates for Merck's products.
In 2005, Hebert joined Integral Orthopedics as vice president of marketing, shareholder and member of the senior executive team. In this capacity, she advanced product innovation through development and commercialization phases, including work with suppliers on product design and advanced medical prototyping. Hebert led aggressive corporate intellectual property protection via case management, better designs and web protection strategies to strengthen the company's defenses against competition. In her executive capacity, she also designed and initiated Integral Orthopedics' internal and external clinical studies and provided oversight on testing of new products in the company's internal research facility, leading to favorable outcomes and the launch of several new products.
"Jeanne's remarkable track record of bringing products to market quickly and successfully – supported by research and sound science – makes her the ideal choice to help guide our company as we seek to introduce a wide array of new products powered by Fuse Science's groundbreaking technology," said Brian Tuffin, Fuse Science President and Chief Operating Officer. "Her addition is further indication that Fuse has the attention of the scientific community and that the applications of our technology reach far beyond our initial product launches into many multi-billion dollar categories.
"I'm excited to join this team," said Jeanne Hebert. "The opportunity exists to advance this technology in many ways to make a major difference in how consumers purchase and consume products in everything from Energy drinks to Pharmaceuticals. The work ahead must remain deliberate and focused and significant value will follow." Tuffin concluded by saying, "We are committed to realizing this strategy and creating significant long-term shareholder value by building a leadership team that is second to none."
About Double Eagle Holdings
Double Eagle Holdings (Pink Sheets: DEGH) is an innovative consumer products holding company and the parent company of Fuse Science, Inc. Based in Aventura, Florida, Fuse Science is the developer of patent-pending conveyance technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals, delivering their benefits faster and more effectively than ever before. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the company's SEC filings. The company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
No comments:
Post a Comment